Radiopharm Theranostics Ltd

Radiopharm Theranostics Ltd (RDPTF) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the near term. However, zero signal in a short window does not indicate absence of risk; earlier events, chronic financing patterns, or shareholder dilution exposure may not yet be visible. The full $49 Report extends analysis to 12 months of SEC filings, maps dilution risk scores across capital raises, contextualizes all 8-K events, and surfaces AI-detected signals in offering documents and financial structure. The full $49 Report adds comprehensive dilution trajectory, complete 12-month event history, and embedded financing risk assessment.